Clinical and molecular characteristics of early progressors (EPs) and long-term progression-free survivors (LTPs) from the phase 3 ADRIATIC trial of consolidation durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC)

Barbie D. A., Xie M., Broggi M., Cheng Y., Spigel D. R., Cho B. C., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 30 May - 03 June 2025, vol.43, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 43
  • Doi Number: 10.1200/jco.2025.43.16_suppl.8014
  • City: Illinois
  • Country: United States Of America
  • Istanbul University Affiliated: No